BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38061978)

  • 1. Epidemiology, Management, and Survival Outcomes of Germ Cell Cancer in Southern Portugal: A Population-Based Study (2008-2012).
    Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
    Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal survival of male germ-cell tumors in southern Portugal--a population-based retrospective study for cases diagnosed in 1999 and 2000.
    Passos-Coelho JL; Castro Ribeiro M; Santos E; Sousa Pontes C; Brito B; Miranda AC
    Ann Oncol; 2011 May; 22(5):1215-1220. PubMed ID: 21030383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialist management of testicular cancer: Report of the last 10 years at a Portuguese tertiary referral academic centre.
    Marques-Pinto A; Gomes AI; Febra J; Rosendo E; Castanheira de Oliveira M; Fraga A; La Fuente de Carvalho J; Louro N
    Arch Ital Urol Androl; 2021 Jun; 93(2):153-157. PubMed ID: 34286547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival patterns for germ cell tumors among 13- to 24-year olds in Yorkshire, UK.
    Feltbower RG; Siller C; Woodward E; McKinney PA; Picton SV; Joffe J; Stark DP
    Pediatr Blood Cancer; 2011 Feb; 56(2):282-8. PubMed ID: 21157895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
    Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
    Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center.
    Necchi A; Farè E; Vullo SL; Giannatempo P; Raggi D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Verzoni E; Grassi P; Procopio G; Pizzocaro G; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2015 Aug; 13(4):385-391.e1. PubMed ID: 25726505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
    Karim S; Wei X; Leveridge MJ; Siemens DR; Robinson AG; Bedard PL; Booth CM
    Urol Oncol; 2019 Mar; 37(3):183.e17-183.e24. PubMed ID: 30478011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
    Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
    Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care and outcomes of men with germ cell tumors in a high-volume Australian center.
    Arasaratnam M; Balakrishnar B; Crumbaker M; Turner S; Hayden AJ; Brooks A; Patel MI; Lau H; Woo H; Bariol S; Gurney H
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e23-e31. PubMed ID: 34152083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
    Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
    J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.
    Feldman DR; Voss MH; Jacobsen EP; Jia X; Suarez JA; Turkula S; Sheinfeld J; Bosl GJ; Motzer RJ; Patil S
    Cancer; 2013 Jul; 119(14):2574-81. PubMed ID: 23606402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
    Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
    Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
    Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
    Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.
    Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G
    Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
    Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
    Actas Urol Esp; 2012 Mar; 36(3):127-45. PubMed ID: 22188753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes.
    Rice KR; Magers MJ; Beck SD; Cary KC; Einhorn LH; Ulbright TM; Foster RS
    J Urol; 2014 Nov; 192(5):1403-9. PubMed ID: 24952240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
    Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
    Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.